Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
1.
Zhonghua Zhong Liu Za Zhi ; 44(10): 1125-1131, 2022 Oct 23.
Artículo en Chino | MEDLINE | ID: mdl-36319459

RESUMEN

Objective: To evaluate the long-term outcomes, failure patterns and prognostic factors of definitive radiotherapy in patients with cervical esophageal carcinoma (CEC). Methods: We retrospectively reviewed the clinical data of 148 CEC patients who treated with definitive radiotherapy in Cancer Hospital of Chinese Academy of Medical Sciences from January 2001 to December 2017. The median radiation dose was 66 Gy (59.4-70 Gy) and 33.1% of patients received concurrent chemotherapy. The Kaplan-Meier method was used to calculate survival rates. The log rank test was used for survival comparison and univariate prognostic analysis. The Cox model was used for multivariate prognostic analysis. Results: The median follow-up time was 102.6 months. The median survival time, 2- and 5-year overall survival (OS) were 22.7 months, 49.9% and 28.3%. The median, 2- and 5-year progression-free survival were 12.6 months, 35.8% and 25.8%. The 2- and 5-year locoregional recurrence-free survival were 59.1% and 50.8%. The 2- and 5-year distant metastases-free survival were 74.6% and 65.9%. Multivariate analysis showed that EQD(2)>66 Gy was the only independent prognostic indicator for OS (P=0.040). The median survival time and 5-year OS rate significantly improved in patients who received EQD(2)>66 Gy than those who received≤66 Gy (31.2 months vs. 19.2 months, 40.1% vs. 19.1%, P=0.027). A total of 87 patients (58.8%) developed tumor progression. There were 50 (33.8%), 23 (15.5%) and 39 (26.4%) patients developed local, regional recurrence and distant metastases, respectively. Eleven patients (7.4%) underwent salvage surgery, and the laryngeal preservation rate for entire group was 93.9%. Conclusions: Definitive radiotherapy is an effective treatment for cervical esophageal carcinoma with the advantage of larynx preservation. Local recurrence is the major failure pattern. EQD(2)>66 Gy is associated with the improved overall survival.


Asunto(s)
Carcinoma , Neoplasias Esofágicas , Humanos , Estudios Retrospectivos , Neoplasias Esofágicas/patología , Carcinoma/tratamiento farmacológico , Pronóstico , Resultado del Tratamiento , Quimioradioterapia/métodos , Dosificación Radioterapéutica
2.
Zhonghua Zhong Liu Za Zhi ; 44(2): 185-191, 2022 Feb 23.
Artículo en Chino | MEDLINE | ID: mdl-35184464

RESUMEN

Objective: To analyze the efficacy of sinonasal adenoid cystic carcinoma (ACC) with perineural invasion (PNI), and explore the prognostic value of PNI on sinonasal adenoid cystic carcinoma. Methods: The clinical data of 105 patients with sinonasal ACC admitted to Cancer Hospital, Chinese Academy of Medical Sciences from January 2000 to December 2016 were retrospectively reviewed. All patients were restaged according to American Joint Committee on Cancer 8th edition. Follow-up visits were conducted to obtain information of treatment failure and survival outcome. The Log rank test was used for univariate analysis of prognostic factors, and Cox regression model was used for multivariate prognostic analysis. Results: The maxillary sinus (n=59) was the most common primary site, followed by the nasal cavity (n=38). There were 93 patients with stage Ⅲ-Ⅳ. The treatment modalities included surgery alone (n=14), radiotherapy alone (n=13), preoperative radiotherapy plus surgery (n=10), and surgery plus postoperative radiotherapy (n=68). The median follow-up time was 91.8 months, the 5-year local control (LC), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS) rates were 72.6%, 73.0%, 52.9% and 78.0%, respectively. There were 33 patients (31.4%) with PNI-positive. The 5-year DMFS, PFS, and OS rates of PNI-positive group were 53.7%, 29.4% and 56.5%, respectively, which were significantly inferior to those of PNI-negative group (80.8%, 63.0% and 86.8%, respectively, P<0.05), while there was no significant difference in the 5-year LC rate between both groups (64.5% vs 76.5%, P=0.273). The multivariate Cox regression analysis showed PNI was one of the poor prognostic factors of DMFS (HR=3.514, 95%CI: 1.557-7.932), PFS (HR=2.562, 95%CI: 1.349-4.866) and OS (HR=2.605, 95%CI: 1.169-5.806). Among patients with PNI-positive, the 5-year LC, PFS and OS rates of patients received surgery combined with radiotherapy were 84.9%, 41.3% and 72.7%, respectively, which were significantly higher than 23.3%, 10.0% and 26.7% of patients receiving surgery or radiotherapy alone (P<0.05). Conclusion: The presence of PNI increases the risk of distant metastasis in patients with sinonasal ACC. Compared with patients with PNI-negative, the prognosis of patients with PNI-positive is relatively poor, and surgery combined with radiotherapy for PNI-positive sinonasal ACC results in good clinical outcomes.


Asunto(s)
Carcinoma Adenoide Quístico , Neoplasias de los Senos Paranasales , Carcinoma Adenoide Quístico/patología , Humanos , Neoplasias de los Senos Paranasales/patología , Neoplasias de los Senos Paranasales/terapia , Pronóstico , Modelos de Riesgos Proporcionales , Estudios Retrospectivos
3.
Zhonghua Xue Ye Xue Za Zhi ; 42(1): 39-44, 2021 Jan 14.
Artículo en Chino | MEDLINE | ID: mdl-33677867

RESUMEN

Objective: To investigate the prognostic significance of different IDH mutations and accompanying gene mutations in patients with non-M(3) acute myeloid leukemia (AML) . Methods: Second-generation sequencing was performed to detect the mutations of 22 genes in 389 patients with AML in the First Affiliated Hospital of Zhengzhou University from June 2016 to December 2018, and Kaplan-Meier and Cox regression models were used to analyze the prognostic factors. Results: The mutation frequency of IDH1 and IDH2 was 6.2% and 8.7% , respectively, in all patients without co-mutation. The IDH2 mutant group had an older age, higher proportion of bone marrow primitive cells, more common normal karyotype, and more common RUNX1 and SRSF2 mutations compared with IDH2 wild-type group. Univariate analysis of variance showed that the median OS and PFS of IDH1 mutation group were significantly shorter than those of the wild-type group (P<0.05) . IDH2 mutation as a single variable and IDH2R140 mutation had no significant effect on the prognosis, while different mutation sites had different effects. Compared with the IDH2 wild-type group, the IDH2R172 mutation group had lower complete remission (CR) rate and shorter median OS and PFS (P<0.05) . In patients with normal karyotypes or aged ≥50 years, IDH2 mutation as a single variable had no significant effect on the prognosis, IDH1 mutation and IDH2R172 mutation were associated with poor OS and PFS (P<0.05) , and IDH2R140 mutation had no significant effect on OS and PFS. Approximately 74.1% (43/58) of patients with IDH mutation simultaneously carried other gene mutations; however, the number of accompanying gene mutations had no significant effect on the prognosis. Among 58 patients with IDH mutation, the CR rate of patients with NPM1 mutation was significantly higher than that of patients in the NPM1 wild-type group (81.8% vs 36.4% , P=0.014) , the median OS in patients with DNMT3A mutation was lower than that of patients with DNMT3A wild type [4.0 months (95% CI 3.8-4.2) vs 6.3 months (95% CI 2.4-10.2) , P=0.041) ]. Multivariate analysis showed that age ≥60 years and white blood cell count ≥100×10(9)/L were independent risk factors for OS and PFS, while CR after two courses of treatment and hematopoietic stem cell transplantation were independent prognostic favorable factors for OS and PFS. Conclusion: In patients with AML (non-M(3)) , IDH gene mutations often coexisted with other gene mutations, and different subtypes and accompanying gene mutations of IDH have different prognostic significance.


Asunto(s)
Isocitrato Deshidrogenasa , Leucemia Mieloide Aguda , Anciano , Humanos , Isocitrato Deshidrogenasa/genética , Leucemia Mieloide Aguda/genética , Persona de Mediana Edad , Mutación , Nucleofosmina , Pronóstico , Inducción de Remisión
5.
Artículo en Inglés | MEDLINE | ID: mdl-27381257

RESUMEN

BACKGROUND: Environmental stress affects the gut with dysmotility being a common consequence. Although a variety of microbes or molecules may prevent the dysmotility, none reverse the dysmotility. METHODS: We have used a 1 hour restraint stress mouse model to test for treatment effects of the neuroactive microbe, L. rhamnosus JB-1™ . Motility of fluid-filled ex vivo gut segments in a perfusion organ bath was recorded by video and migrating motor complexes measured using spatiotemporal maps of diameter changes. KEY RESULTS: Stress reduced jejunal and increased colonic propagating contractile cluster velocities and frequencies, while increasing contraction amplitudes for both. Luminal application of 10E8 cfu/mL JB-1 restored motor complex variables to unstressed levels within minutes of application. L. salivarius or Na.acetate had no treatment effects, while Na.butyrate partially reversed stress effects on colonic frequency and amplitude. Na.propionate reversed the stress effects for jejunum and colon except on jejunal amplitude. CONCLUSIONS & INFERENCES: Our findings demonstrate, for the first time, a potential for certain beneficial microbes as treatment of stress-induced intestinal dysmotility and that the mechanism for restoration of function occurs within the intestine via a rapid drug-like action on the enteric nervous system.


Asunto(s)
Motilidad Gastrointestinal/fisiología , Lacticaseibacillus rhamnosus , Probióticos/administración & dosificación , Estrés Psicológico/dietoterapia , Estrés Psicológico/fisiopatología , Animales , Enfermedades Gastrointestinales/dietoterapia , Enfermedades Gastrointestinales/fisiopatología , Motilidad Gastrointestinal/efectos de los fármacos , Masculino , Ratones , Complejo Mioeléctrico Migratorio/efectos de los fármacos , Complejo Mioeléctrico Migratorio/fisiología , Técnicas de Cultivo de Órganos , Restricción Física/efectos adversos
6.
Neurogastroenterol Motil ; 25(3): e205-14, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23316914

RESUMEN

BACKGROUND: Commensal bacteria such as probiotics that are neuroactive acutely affect the amplitudes of intestinal migrating motor complexes (MMCs). What is lacking for an improved understanding of these motility effects are region specific measurements of velocity and frequency. We have combined intraluminal pressure recordings with spatiotemporal diameter maps to analyze more completely effects of different strains of beneficial bacteria on motility. METHODS: Intraluminal peak pressure (PPr) was measured and video recordings made of mouse ex vivo jejunum and colon segments before and after intraluminal applications of Lactobacillus rhamnosus (JB-1) or Lactobacillus reuteri (DSM 17938). Migrating motor complex frequency and velocity were calculated. KEY RESULTS: JB-1 decreased jejunal frequencies by 56% and 34% in colon. Jejunal velocities increased 171%, but decreased 31% in colon. Jejunal PPr decreased by 55% and in colon by 21%. DSM 17938 increased jejunal frequencies 63% and in colon 75%; jejunal velocity decreased 57%, but increased in colon 146%; jejunal PPr was reduced 26% and 12% in colon. TRAM-34 decreased frequency by 71% and increased velocity 200% for jejunum, but increased frequency 46% and velocity 50% for colon; PPr was decreased 59% for jejunum and 39% for colon. CONCLUSIONS & INFERENCES: The results show that probiotics and other beneficial bacteria have strain and region-specific actions on gut motility that can be successfully discriminated using spatiotemporal mapping of diameter changes. Effects are not necessarily the same in colon and jejunum. Further research is needed on the detailed effects of the strains on enteric neuron currents for each gut region.


Asunto(s)
Colon/microbiología , Yeyuno/microbiología , Lacticaseibacillus rhamnosus , Limosilactobacillus reuteri , Complejo Mioeléctrico Migratorio/fisiología , Animales , Colon/fisiología , Yeyuno/fisiología , Masculino , Ratones , Técnicas de Cultivo de Órganos , Probióticos/farmacología , Grabación en Video
7.
Methods Find Exp Clin Pharmacol ; 25(6): 447-52, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12949630

RESUMEN

A mixture of traditional Chinese herbs ('FTDA') was found to improve several oxidation-related biomarkers in D-galactose-induced mimetic aging mice. FTDA consists of seven herbal components: Cuscutae Semen, Schisandrae Fructus, Dioscoreae Rhizoma, Lonicerae Flos, Nelumbinis Semen, Angelica Radix and Poria, and is routinely used for treating mice with D-galactose-induced oxidative damage. Measurements of antioxidant status, including superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), total antioxidant status (TAS) and malondialdehyde (MDA) were made on blood, brain and liver tissue collected from animals after 60 days of treatment with D-galactose subcutaneous injections. High-dose, medium-dose and control groups exhibited higher levels of SOD, GSH-Px and TAS in their blood, as well as lower levels of serum MDA activity, compared with the D-galactose group. In the liver, all three experimental and PBS groups demonstrated significant increases in SOD activity and a decrease in MDA activity. The MDA activity decreased in medium-dose, high-dose and PBS groups, while medium-dose and PBS groups demonstrated increased SOD activity compared with that seen in the brain. These results support the efficacy of FTDA in improving the antioxidant status of D-galactose-induced mimetic aging mice.


Asunto(s)
Antioxidantes/farmacología , Medicamentos Herbarios Chinos/farmacología , Galactosa/toxicidad , Estrés Oxidativo/efectos de los fármacos , Animales , Antioxidantes/metabolismo , Encéfalo/metabolismo , Eritrocitos/metabolismo , Glutatión Peroxidasa/sangre , Hígado/metabolismo , Masculino , Malondialdehído/sangre , Malondialdehído/metabolismo , Ratones , Ratones Endogámicos C57BL , Estrés Oxidativo/fisiología , Superóxido Dismutasa/sangre , Superóxido Dismutasa/metabolismo
8.
J Ultrasound Med ; 19(11): 771-82, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11065266

RESUMEN

This paper describes the development of a model-based boundary recognition system for transrectal prostate ultrasonographic images. It consists of two techniques: boundary modeling and boundary searching with model constraints. To achieve higher specificity of the model, a method called feature modeling is derived from the existing point distribution modeling method. To improve the robustness of the searching technique, the genetic algorithm is used. Incremental genetic algorithm with crowding replacement and binary string chromosome type was found experimentally to give good search results. It was shown that the system could recognize the boundary with considerable accuracy and consistency within a few minutes in transrectal ultrasonographic images taken from approximate middle position of the prostate.


Asunto(s)
Algoritmos , Modelos Genéticos , Modelos Estadísticos , Próstata/diagnóstico por imagen , Humanos , Procesamiento de Imagen Asistido por Computador , Masculino , Distribución Normal , Variaciones Dependientes del Observador , Ultrasonografía
9.
J Cell Biochem ; 79(3): 460-70, 2000 Sep 07.
Artículo en Inglés | MEDLINE | ID: mdl-10972983

RESUMEN

Magnetic fields (MFs) of various characteristics can lead to plethora effects in biological system. From a molecular point of view, we hypothesized that there must be a fundamental difference in gene expression between the MF exposed and the unexposed cell. To identify the classes of genes that are regulated, 0.8 mT 50 Hz MF-induced changes in gene expression were examined in a Daudi cell culture using differential display and reverse transcriptase-polymerase chain reaction. A candidate cDNA (signatured as MF-CB) that was observed in the sham-exposed but not in MF-exposed cultures was recovered and reamplified. After verification by Northern blot, the cDNA was cloned and sequenced. It was found that 254-base pair of 5'-end MF-CB cDNA clone was identical to gcs in open reading frame (ORF) range. Based on the preliminarily sequence, the prolonged length of 5'-end MF-CB cDNA was obtained by PCR amplification and its sequence analysis showed the same results as its original fragment. In order to further determine whether MF-CB cDNA is from gcs, two Northern blots were probed with gcs and MF-CB cDNA, respectively, and the data revealed signals of the same size and expression pattern on the two probe filters, which demonstrated that MF-CB is an EST (expression sequence tag) of gcs. gcs is a gene, identified recently (GenBank accession number D89866), encoding ceramide glucosyltransferase (GCS), which has been implicated as a causal element in human cell growth and differentiation. In an additional experiment, time-dependent changes in the transcription of gcs induced by 0.8 mT MF were observed by Northern blot with a sharp and reproducible inhibition effect after 20 min exposure and a reduction after 20-24 h exposure. The study demonstrates for the first time that 50 Hz MF can lead to changes in gcs transcription, which provides a new clue to elucidate the mechanism by which MF influence cell growth and differentiation.


Asunto(s)
Linfoma de Burkitt/patología , Perfilación de la Expresión Génica , Regulación Neoplásica de la Expresión Génica/efectos de la radiación , Glucosiltransferasas/genética , Magnetismo , Proteínas de Neoplasias/genética , ARN Mensajero/biosíntesis , ARN Neoplásico/biosíntesis , Técnica de Sustracción , Transcripción Genética/efectos de la radiación , Secuencia de Aminoácidos , Secuencia de Bases , Northern Blotting , Linfoma de Burkitt/genética , Clonación Molecular , ADN Complementario/genética , Inducción Enzimática/efectos de la radiación , Glucosiltransferasas/biosíntesis , Humanos , Datos de Secuencia Molecular , Proteínas de Neoplasias/biosíntesis , Reacción en Cadena de la Polimerasa , Homología de Secuencia de Ácido Nucleico , Células Tumorales Cultivadas/metabolismo , Células Tumorales Cultivadas/efectos de la radiación
10.
Genes Dev ; 12(14): 2153-63, 1998 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-9679060

RESUMEN

Smads regulate transcription of defined genes in response to TGF-beta receptor activation, although the mechanisms of Smad-mediated transcription are not well understood. We demonstrate that the TGF-beta-inducible Smad3 uses the tumor suppressor Smad4/DPC4 and CBP/p300 as transcriptional coactivators, which associate with Smad3 in response to TGF-beta. The association of CBP with Smad3 was localized to the carboxyl terminus of Smad3, which is required for transcriptional activation, and a defined segment in CBP. Furthermore, CBP/p300 stimulated both TGF-beta- and Smad-induced transcription in a Smad4/DPC4-dependent fashion. Smad3 transactivation and TGF-beta-induced transcription were inhibited by expressing E1A, which interferes with CBP functions. The coactivator functions and physical interactions of Smad4 and CBP/p300 with Smad3 allow a model for the induction of gene expression in response to TGF-beta.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Genes Supresores de Tumor , Proteínas Nucleares/metabolismo , Transactivadores/metabolismo , Activación Transcripcional , Factor de Crecimiento Transformador beta/metabolismo , Proteínas E1A de Adenovirus/metabolismo , Animales , Sitios de Unión , Células COS , Proteína de Unión a CREB , Proteínas de Unión al ADN/genética , Humanos , Proteínas Nucleares/genética , Nucleoproteínas/metabolismo , Inhibidor 1 de Activador Plasminogénico/genética , Regiones Promotoras Genéticas , Proteína Smad2 , Proteína smad3 , Proteína Smad4 , Transactivadores/genética , Transcripción Genética , Células Tumorales Cultivadas
11.
Mol Cell Biol ; 17(5): 2521-8, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9111321

RESUMEN

Homologs of Drosophila Mad function as downstream mediators of the receptors for transforming growth factor beta (TGF-beta)-related factors. Two homologs, the receptor-associated Smad3 and the tumor suppressor Smad4/DPC4, synergize to induce ligand-independent TGF-beta activities and are essential mediators of the natural TGF-beta response. We now show that Smad3 and Smad4 associate in homomeric and heteromeric interactions, as assessed by yeast two-hybrid and coimmunoprecipitation analyses. Heteromeric interactions are mediated through the conserved C-terminal domains of Smad3 and Smad4. In Smad3, the homomeric interaction is mediated by the same domain. In contrast, the homomeric association of Smad4 requires both the N-terminal domain and the C-terminal domain, which by itself does not homomerize. Mutations that have been associated with impaired Mad activity in Drosophila or decreased tumor suppressor activity of Smad4/DPC4 in pancreas cancer, including a short C-terminal truncation and two point mutations in the conserved C-terminal domains, impair the ability of Smad3 and Smad4 to undergo homo- and heteromeric associations. Analyses of the biological activity of Smad3 and Smad4 and their mutants show that full signaling activity correlates with their ability to undergo efficient homo- and heteromeric interactions. Mutations that interfere with these interactions result in decreased signaling activity. Finally, we evaluated the ability of Smad3 or Smad4 to induce transcriptional activation in yeast. These results correlate the ability of individual Smads to homomerize with transcriptional activation and additionally with their biological activity in mammalian cells.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Genes Supresores de Tumor , Transducción de Señal , Transactivadores/metabolismo , Animales , Células COS , Mapeo Cromosómico , Secuencia Conservada , Conformación Proteica , Proteína smad3 , Transcripción Genética , Transfección
12.
J Biol Chem ; 271(22): 12691-4, 1996 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-8662982

RESUMEN

The ret/ptc2 papillary thyroid cancer oncogene, an oncogenic form of the c-Ret receptor tyrosine kinase, is the product of a somatic crossover event fusing the dimerization domain of the type Ialpha regulatory subunit of cyclic AMP-dependent protein kinase (RI) with the tyrosine kinase domain of c-Ret. Mitogenic activity of Ret/ptc2 required dimerization via the N terminus of RI and a tyrosine residue located C-terminal to the kinase core of Ret, Tyr-586 (Durick, K., Yao, V. J., Borrello, M. G., Bongarzone, I., Pierotti, M. A. and Taylor, S. S. (1995) J. Biol. Chem. 270, 24642-24645). Using the yeast two-hybrid system, Ret/ptc2 binding proteins were identified, and the sites of interaction with Ret/ptc2 were mapped. The SH2 domains of phospholipase Cgamma and Grb10 were both identified, and binding depended on phosphorylation of Tyr-539 and Tyr-429, respectively. These interactions, however, were not required for mitogenic signaling. The second of the three LIM domains in Enigma (Wu, R. Y., and Gill, G. N. (1994) J. Biol. Chem. 269, 25085-25090) was also identified as a Ret/ptc2 binding domain. Enigma, a 455-residue protein, was discovered based on its interaction with the insulin receptor through the C-terminal LIM domain. Although the association with Enigma required Tyr-586 of Ret/ptc2, the interaction was phosphorylation-independent. In contrast to the SH2 interactions, disruption of the interaction with Enigma abolished Ret/ptc2 mitogenic signaling, suggesting that LIM domain recognition of an unphosphorylated tyrosine-based motif is required for Ret signal transduction.


Asunto(s)
Proteínas Portadoras/metabolismo , Péptidos y Proteínas de Señalización Intracelular , Mitógenos/metabolismo , Proteínas Oncogénicas/metabolismo , Proteínas Tirosina Quinasas Receptoras/metabolismo , Transducción de Señal , Células 3T3 , Proteínas Adaptadoras Transductoras de Señales , Animales , Proteínas del Citoesqueleto , Proteínas con Dominio LIM , Ratones , Proteínas Oncogénicas/genética , Unión Proteica , Proteínas Proto-Oncogénicas c-ret , Proteínas Tirosina Quinasas Receptoras/genética , Saccharomyces cerevisiae/genética , Dominios Homologos src
13.
Yao Xue Xue Bao ; 31(12): 906-10, 1996.
Artículo en Chino | MEDLINE | ID: mdl-9863223

RESUMEN

This study is to determine whether sensory neuropeptides are involved in the cardiovascular effects of leukotriene C4 (LTC4). LTC4 (0.8 nmol.kg-1, i.v.) caused hypotensive response and increased Evans blue extravasation from the atria and ventricles in anaesthetized guinea pigs. CP-96345 (2.06 mumol.kg-1, i.v.), a tachykinin NK-1 receptor antagonist, and SR-48968 (1.66 mumol.kg-1, i.v.), an NK-2 receptor antagonist, partially inhibited LTC4-induced increase (46.6% and 37.5%, respectively) of dye extravasation from the atria of guinea pigs. Combination of CP-96345 and SR-48968 markedly inhibited LTC4-induced hypotension and increase of microvascular leakage in both atria and ventricles (58.1% and 54.1%, respectively), similar to the inhibition by ONO-1078 (0.06 mumol.kg-1, i.v.), a specific leukotriene antagonist. These results suggest that NK-1 and NK-2 receptors may be involved in the hypotension and the inflammation of heart induced by LTC4.


Asunto(s)
Benzamidas/farmacología , Compuestos de Bifenilo/farmacología , Leucotrieno C4/antagonistas & inhibidores , Antagonistas del Receptor de Neuroquinina-1 , Piperidinas/farmacología , Receptores de Neuroquinina-2/antagonistas & inhibidores , Animales , Presión Sanguínea/efectos de los fármacos , Femenino , Cobayas , Masculino
14.
Bioelectromagnetics ; 16(1): 70-4, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7748205

RESUMEN

Eighty-nine Swiss Webster mice were randomly divided into four groups: a control group, a pulsed magnetic field (PMF) group, a cytosine arabinoside (ara-C, a teratogen) group, and a combined PMF + ara-C group. Mice in the PMF and PMF + ara-C groups were irradiated with a PMF (a sawtooth waveform with 52 microseconds rise time, 12 microseconds decay time, and 15.6 kHz frequency) at a peak magnetic flux density of 40 microT for 4 hours daily on days 6-17 of gestation. The mice in the ara-C and the PMF + ara-C groups were injected intraperitoneally on day 9 of gestation with 10 mg/kg of ara-C. The incidence of resorption and dead fetuses was not affected by PMF but was increased by ara-C injection. The malformation incidence of cleft palate (CP) and/or cleft lip (CL) was significantly higher in all three of the treated groups than in the control group (P < 0.05). If, however, statistical analyses had been done on litters rather than on individual fetuses, they would show that the incidence of CP and/or CL in the PMF group is not significantly greater than that in the control group. A significantly higher incidence of CP and/or CL was found in the PMF + ara-C group (49%) than the ara-C alone group (26.1%). These data suggest that PMF might enhance the development of ara-C-induced CP and/or CL. The incidence of minor variations in skeletal development, including reduction of skeletal calcification and loss of skeleton, was not statistically significant in the PMF group.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Anomalías Inducidas por Medicamentos/etiología , Terminales de Computador , Citarabina/efectos adversos , Campos Electromagnéticos/efectos adversos , Animales , Peso Corporal/efectos de los fármacos , Peso Corporal/efectos de la radiación , Huesos/efectos de los fármacos , Huesos/efectos de la radiación , Calcificación Fisiológica/efectos de los fármacos , Calcificación Fisiológica/efectos de la radiación , Labio Leporino/etiología , Fisura del Paladar/etiología , Femenino , Muerte Fetal/etiología , Reabsorción del Feto/etiología , Masculino , Ratones , Embarazo
17.
J Biol Chem ; 269(40): 25085-90, 1994 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-7929196

RESUMEN

Endocytosis of cell surface receptors requires sequence "codes" consisting of tight turn structures with an essential Tyr or Phe residue. To determine mechanisms through which cells recognize this information, we utilized exon 16 of the human insulin receptor in the two-hybrid system to isolate a novel 455-amino acid cytoplasmic protein that contains two LIM domains within its carboxyl terminus. Mutational analyses indicate that one of the Cys-rich Zn2+ binding LIM domains specifically recognizes active but not inactive endocytic codes contained in exon 16. These findings suggest that LIM domain structures in proteins provide molecular recognition of Tyr-containing tight turn structures.


Asunto(s)
Endocitosis , Proteínas de Homeodominio , Proteínas del Tejido Nervioso , Receptor de Insulina/química , Secuencia de Aminoácidos , Secuencia de Bases , Proteínas de Unión al ADN , Exones , Proteínas con Homeodominio LIM , Datos de Secuencia Molecular , Receptor de Insulina/genética , Factores de Transcripción , Tirosina , Zinc/metabolismo
18.
Bioelectromagnetics ; 15(6): 531-8, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7880166

RESUMEN

The purpose of this study was to investigate the effects of 2.45 GHz microwave (MW) radiation on dimethylhydrazine (DMH)-induced colon cancer in mice. The subjects were 115 Balb/c mice 4 weeks of age. The animals were divided into group A (control), group B (DMH), group C (DMH+MW), and group D [DMH + 12-O-tetradecanoylphorbol-13- acetate (TPA)]. Radiation (10 mW/cm2) was delivered dorsally with the E field parallel to the mouse's long body axis in an anechoic chamber. Radiations were administered 3 hr daily, 6 days per week, over a period of 5 months. The average SAR was estimated to be 10-12 W/kg. During the course of radiation treatments, DMH was injected once per week. The tumor promoter TPA was administered once per week for 10 weeks, from the third week on, after the initial treatment. The incidence of tumors did not significantly differ between the three test groups (groups B, C, and D; P > 0.25). However, the number of tumors, the size of the tumors, and the incidence of protuberant and infiltrative types in tumor-bearing animals were higher in group D compared to groups B and C (P < 0.05). No difference was found between groups B and C (P > 0.25). The study indicates that 2.45 GHz microwave radiation at 10 mW/cm2 power density did not promote DMH-induced colon cancers in young mice. The study also showed that TPA could accelerate colon tumor production if a tumor was initiated.


Asunto(s)
Cocarcinogénesis , Neoplasias del Colon/inducido químicamente , Dimetilhidrazinas/efectos adversos , Microondas , Acetato de Tetradecanoilforbol/efectos adversos , Pólipos Adenomatosos/inducido químicamente , Pólipos Adenomatosos/etiología , Pólipos Adenomatosos/patología , Animales , Carcinoma/inducido químicamente , Carcinoma/etiología , Carcinoma/patología , Neoplasias del Colon/etiología , Neoplasias del Colon/patología , Pólipos del Colon/inducido químicamente , Pólipos del Colon/etiología , Pólipos del Colon/patología , Femenino , Masculino , Ratones , Ratones Endogámicos BALB C , Microondas/efectos adversos , Neoplasias Inducidas por Radiación/etiología , Neoplasias Inducidas por Radiación/patología , Dosis de Radiación
20.
J Antibiot (Tokyo) ; 41(4): 481-7, 1988 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3372354

RESUMEN

A new cytotoxic and antifungal antibiotic, neihumicin, was isolated from the culture broth of a soil isolate identified as Micromonospora neihuensis Wu, sp. nov. Neihumicin shows in vitro cytotoxicity against KB tissue culture cells (ED50 0.94 micrograms/ml) as well as antifungal activity against Saccharomyces cerevisiae ATCC 9763.


Asunto(s)
Antibióticos Antineoplásicos/aislamiento & purificación , Antifúngicos/aislamiento & purificación , Micromonospora/metabolismo , Antibióticos Antineoplásicos/farmacología , Antifúngicos/farmacología , Fermentación , Hongos/efectos de los fármacos , Micromonospora/ultraestructura , Pirazinas/aislamiento & purificación , Pirazinas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA